Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +47.43%
#3 Pons Pons +45.47%
#4 Non-Playable Coin Non-Playable Coin +27.80%
#5 StonkBroker StonkBroker +27.01%
#6 ApeX ApeX +25.69%
#7 Kinetiq Kinetiq +25.58%
#8 Pudgy Penguins Pudgy Penguins +21.53%
#9 OriginTrail OriginTrail +19.79%
#10 Grass Grass +19.50%
Coin of the day
Smilek to the Bank Smilek to the Bank
設定
言語
日本
通貨
USD
テーマ
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
株式のランク #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
株価
$2.72
最終同期: 2023-10-19
時価総額
$111.47M
変化（1日）
-0.73%
変化（1年）
0.00%
国
US
取引 Talaris Therapeutics, Inc. (TALS)

カテゴリー

Healthcare
Talaris Therapeutics, Inc.（TALS）の配当履歴
Talaris Therapeutics, Inc.（証券コード：TALS）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのTalaris Therapeutics, Inc.（TALS）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH